ESC 22: Hot Line & Late-breaking Science Video Collection

Published: 24 August 2022

  • Views:

    Views Icon 3163
  • Likes:

    Heart Icon 7

Overview

What's hot at European Society of Cardiology (ESC) Congress 22?

Stay tuned and browse our curated coverage of the latest data in cardiology. 

  • For a concise line up of the most awaited trials join Prof Nicolas Van Mieghem and Dr Joost Daemen and their regular View From the Thoraxcenter series. 
  • For a deeper dive into key clinical trial data and applicability, host, Dr Harriette Van Spall talks with principal investigators in her Late-Breaker Discussion Series
  • Short, accessible Expert Interviews conducted with select faculty focusing on data, patient care and the future of their field. 
  • To mark the release of the new ESC Guidelines on Cardio-Oncology, we will feature a 10-minute summary and of t a 10-minute live audience Q&A.
  • We asked some of the most prominent researchers today about their pathways in the Behind the Heart series.

Watch our Radcliffe Premiere TV and be transported to Barcelona. 

More from this programme

Part 1

View From the Thoraxcenter: Review Series

In this short and engaging episode of View from the Thoraxcenter, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) share their take on the most impactful hot-line and late-breaking trials from ESC 2022. Which trials should we look out for?

Part 2

Late-breaker Discussion Series With Dr Harriette Van Spall

The Late-breaker discussion series will spotlight some of the most awaited hot line trials from this year's ESC. Stay tuned.

Part 3

ESC Guidelines on Cardio-Oncology: Summary & Question Time

In the first part of the programme chairs of the new ESC Guidelines on Cardio-Oncology, Dr Alexander Lyon and Dr Teresa López-Fernández summarised the key take-home messages.In the second part they answered questions coming from the audience with the moderation of Dr Arjun Ghosh.

Part 4

Hot Line & Late-breaking Interviews

In this series, we will interview the presenters of 20 hot line and late-breaking trials to give you a quick updated on the hottest data in cardiology.

Faculty Biographies

Harriette Van Spall

Harriette Van Spall

Associate Professor of Medicine, Director of E-Health and Virtual Care

Dr Harriette Van Spall is an Associate Professor of Medicine and cardiologist and serves as Director of E-Health at McMaster University, Canada. She completed her medical and postgraduate clinical training at the University of Toronto and earned a Master of Public Health degree at Harvard University, US. Dr Van Spall is a Canadian Institutes of Health Research-funded clinical trialist and researcher with a focus on heart failure, health services, and health disparities.

She has garnered more than $4 million in research funding, has won several research awards, and has published her work in high-impact medical journals. She is an invited speaker, media correspondent, and editorial board member active in peer review at several high-impact medications journals and grant funding agencies, including Canadian Institutes of Health Research and Heart and Stroke Foundation of Canada.

Dr Van Spall is an Editorial Board…

View full profile
Divaka Perera

Divaka Perera

Divaka Perera is a Professor of Interventional Cardiology in the School of Cardiovascular Medicine & Sciences and an Honorary Cardiologist at Guy’s and St Thomas’ Hospital. He graduated in medicine from Cambridge University, undertook cardiology specialist training in London and Sussex and received a Clinical Senior Lectureship Award from the Higher Education Funding Council for England in 2008. In 2013, he received the BCS Michael Davies Early Career Award for contribution to cardiovascular science. 

He runs a translational research programme into the mechanisms and consequences of reduced blood supply to the heart muscle in chronic coronary artery disease, acute myocardial infarction and valve disease. He is also involved in designing and performing multicentre clinical trials to evaluate novel treatments for patients with ischaemic heart disease. He is the chief investigator of the NIHR-funded UK multi-centre randomised control trial REVIVED, which seeks to clarify…

View full profile